Press Releases

Jul 08, 2008 Hemispherx Biopharma's Ampligen® NDA for Chronic Fatigue Syndrome Accepted for Review by the FDA

Jun 16, 2008 Hemispherx Biopharma, Inc. Announces Settlement of Arbitration with Laboratorios del Dr. Esteve

Jun 02, 2008 Hemispherx Biopharma, Inc. Completes Enrollment in Phase II Study of Ampligen® as Seasonal Flu Vaccine Enhancer

May 13, 2008 HEMISPHERX BIOPHARMA, INC. RELEASES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2008

Apr 07, 2008 HEMISPHERX BIOPHARMA, INC. ACCELERATES AMPLIGEN® AS A POTENTIAL ADJUVANT FOR BOTH AVIAN INFLUENZA AND HIV VACCINES

Apr 07, 2008 HEMISPHERX BIOPHARMA TO HOST INVESTOR CONFERENCE CALL

Mar 18, 2008 HEMISPHERX BIOPHARMA, INC. ANNOUNCES 2007 FINANCIAL RESULTS

Mar 06, 2008 HEMISPHERX BIOPHARMA REACHES AGREEMENT WITH FDA ON SPECIFIC STEPS TO ACHIEVE COMPLETE NDA ON PROPOSED CFS TREATMENT

Feb 26, 2008 Hemispherx Biopharma to Present at Jesup & Lamont Conference

Feb 11, 2008 Hemispherx Biopharma to Present at New York Bio Conference

50 51 52 53 54 55 56 57 58 59 60

<< < > >>